Momenta Pharmaceuticals, founded by Christoph Westphal as CEO, Announces Completion of Proposed Sale to Johnson & Johnson October 1, 2020
Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist September 25, 2020
